Business Context and Reporting Period
Company: Hercules Technology Growth Capital, Inc. (HTGC)
Filing Type: Form 10-Q (Unaudited)
Period Ended: June 30, 2013
Business Overview: HTGC is an internally managed, non-diversified closed-end investment company regulated as a Business Development Company (BDC) and taxed as a Regulated Investment Company (RIC). The company focuses on providing senior secured loans to venture capital-backed companies in technology-related markets, including biotechnology, life sciences, and clean technology.
Key Financial Metrics
| Metric | Six Months Ended June 30, 2013 | Six Months Ended June 30, 2012 |
|---|---|---|
| Total Investment Portfolio Value | $1,041.1 million | $906.3 million |
| Net Investment Income | $32.6 million | $23.7 million |
| Net Realized Gain on Investments | $4.2 million | $11.1 million |
| Net Unrealized Appreciation (Depreciation) | $0.7 million | $(17.7 million) |
| Net Increase in Net Assets from Operations | $37.6 million | $17.2 million |
| Net Asset Value (NAV) per Share | $10.09 | $9.54 |
| Total Liabilities | $589.0 million | $607.7 million |
| Cash and Cash Equivalents | $133.9 million | $56.1 million |
| Weighted Average Debt Outstanding | $589.2 million | $302.1 million |
Material Changes vs. Prior Period
- Portfolio Growth: The total investment portfolio increased by approximately 14.9% year-over-year, driven by new fundings of $337.9 million in debt and $2.0 million in equity during the six-month period.
- Income Growth: Net investment income increased by 37.6% compared to the prior year period, primarily due to portfolio growth and increased fee income from early payoffs.
- Realized Gains: Net realized gains decreased significantly to $4.2 million from $11.1 million in the prior year. This was due to lower gross realized gains ($9.6 million vs. $12.2 million) and higher gross realized losses ($5.5 million vs. $1.0 million), including the write-off of equity in E-Band Communications, Corp.
- Unrealized Performance: The company recorded a net unrealized appreciation of $0.7 million, a significant improvement from the $17.7 million net unrealized depreciation recorded in the same period in 2012.
- Debt Structure: Total debt outstanding increased due to the issuance of $170.4 million in 2019 Notes and $110.3 million in Asset-Backed Notes, partially offset by repayments of credit facilities.
Guidance, Outlook, and Risks
- Dividend Policy: On July 29, 2013, the Board increased the quarterly dividend by $0.01 to $0.28 per share. The company aims to distribute approximately 90-100% of taxable income.
- Liquidity: As of June 30, 2013, the company had $238.9 million in available liquidity, including $133.9 million in cash and $105.0 million in available borrowing capacity under credit facilities (Wells and Union Bank).
- Capital Resources: The company raised approximately $95.8 million in a public offering of common stock in March 2013. It maintains $225.0 million in SBA debentures, reaching the maximum statutory limit for funds under common control.
- Risks and Contingencies:
- Valuation Risk: Approximately 86% of assets are Level 3 investments valued in good faith by the Board, which may differ from market values if a liquid market existed.
- Credit Risk: Two loans were on non-accrual status at period end. The weighted average investment grading was 2.11 (on a scale of 1-5).
- Regulatory Compliance: The company must maintain asset coverage ratios under the 1940 Act. As of June 30, 2013, the ratio was 337.2% (excluding SBA debentures) and 206.6% (including SBA debentures).
Key Facts for Investor Verification
- Portfolio Concentration: The top four industries (Drug Discovery, Clean Tech, Internet Services, Medical Devices) comprised approximately 60% of the portfolio.
- Unfunded Commitments: The company has $169.1 million in unfunded contractual commitments, of which $95.1 million is contingent on portfolio companies reaching specific milestones.
- Payment-in-Kind (PIK) Interest: The company recorded $1.8 million in PIK income for the six-month period, which is non-cash income that must be distributed as dividends to maintain RIC status.
- Subsequent Events: Several portfolio company acquisitions were announced in July 2013, including iWatt, Inc. (acquired by Dialog Semiconductor) and ENTrigue Surgical, Inc. (acquired by ArthroCare Corp.).